Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.
Erica S TsangJonathan M LoreeJanine M DaviesSharlene GillDavid LiuStephen HoDaniel J RenoufHoward J LimHagen F KenneckePublished in: Canadian journal of gastroenterology & hepatology (2020)
In our population-based cohort, Y-90 was well-tolerated in patients with metastatic liver-dominant NETs. Prior surgical resection was an important predictor of OS.